ALLO- Allogene Therapeutics, Inc.

Name: Allogene Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Allogene Therapeutics, Inc. (ALLO) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. ALLO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Parker Geoffrey M.	1.28M	$2.97M	-
VP	Beneski Benjamin MacHinas	217.7K	$507.3K	-
Dir	Sato Vicki L	144.4K	$336.5K	-
Dir	Mayo Stephen	95.4K	$222.3K	-
Dir	Witte Owen N.	95.4K	$222.3K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Oct 6, 2020	Moore Alison69	Chief Technical Officer	Sale+OE	44,574	$40.00	$1,782,960.00	-27.5%
Oct 6, 2020	Bhavnagri Veer87	General Counsel	Sale+OE	10,000	$40.00	$400,000.00	-2.7%
Oct 1, 2020	Bhavnagri Veer87	General Counsel	Sale+OE	25,000	$36.52	$912,912.73	-2.3%
Oct 1, 2020	Amado Rafael65	EVP Of R&D And CMO	Sell	9,752	$36.37	$354,661.71	-7.1%
Sep 21, 2020	Schmidt Eric Thomas	Chief Financial Officer	Sell	15,000	$35.30	$529,544.76	-0.4%
Sep 1, 2020	Bhavnagri Veer87	General Counsel	Sale+OE	25,000	$35.36	$883,966.00	-3.4%
Aug 7, 2020	Tpg Group Holdings (sbs) Advisors, Inc.86	10% Owner	Sell	37,445	$37.47	$1,403,030.54	-
Aug 3, 2020	Bhavnagri Veer87	General Counsel	Sale+OE	31,553	$36.89	$1,164,120.81	-4.2%
Jun 30, 2020	Tpg Group Holdings (sbs) Advisors, Inc.86	10% Owner	Sell	85,151	$42.53	$3,621,601.10	-0.1%
Jun 25, 2020	Tpg Group Holdings (sbs) Advisors, Inc.86	10% Owner	Sell	219,853	$44.04	$9,682,650.57	-0.3%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC